Gulf Pharmaceutical Industries (Julphar) on Friday announced a net revenue of AED273.4 million from continuing operations in Q1 2026, reflecting a year-on-year decrease of 3.0 percent, while delivering improved profitability.
The Emirates Drug Establishment (EDE) has set up a task force comprising 16 strategic partners involved in pharmaceutical and logistics supply chains across the UAE, including drug manufacturers, medical warehouses, storage facilities and logistics providers.
Julphar (Gulf Pharmaceutical Industries) has signed a long-term lease agreement with Modon 3rd Industrial City in Jeddah to establish an integrated pharmaceutical manufacturing facility.
Eli Lilly and Company (Lilly) and Mubadala Bio have announced a strategic collaboration to advance the localised packaging and logistics of Lilly’s GLP-1 medicines in Abu Dhabi, marking an important step in a shared commitment to advancing the emirate’s growing life sciences ecosystem.
